SCHEMBL18989893

SCHEMBL18989893

Cn1c(Nc2ccncc2)nc2c1c(=O)n(Cc1cc3c(Br)cccc3n1C(=O)OC(C)(C)C)c(=O)n2C

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.39
▸ HIF1A Q16665 4/20 0.39
▸ HPGD P15428 2/20 0.39
▸ MEN1 O00255 5/20 0.39
▸ KMT2A Q03164 5/20 0.39
▸ MAPT P10636 6/20 0.37
▸ PKM P14618 3/20 0.37
▸ LMNA P02545 3/20 0.37
▸ HTT P42858 2/20 0.37
▸ STAT6 P42226 1/20 0.37
▸ POLB P06746 3/20 0.37
▸ CTDSP1 Q9GZU7 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ MTHFD2 P13995 2/20 0.36
▸ TSHR P16473 2/20 0.36
▸ TP53 P04637 2/20 0.35
▸ THRB P10828 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18992724 0.92 MTHFD2 (0.37) ALDH1A1HIF1AHPGDMEN1KMT2A
SCHEMBL18992809 0.91 MTHFD2 (0.43) ALDH1A1HIF1AHPGDMEN1KMT2A
SCHEMBL20592196 0.91 ALDH1A1 (0.40) ALDH1A1HIF1AHPGDMEN1KMT2A
SCHEMBL18992475 0.91 POLB (0.38) ALDH1A1HIF1AHPGDMEN1KMT2A
SCHEMBL18992871 0.89 POLB (0.39) ALDH1A1HIF1AHPGDMEN1KMT2A
SCHEMBL18990268 0.89 POLB (0.41) ALDH1A1HIF1AMEN1KMT2AMAPT
SCHEMBL18992530 0.86 MEN1 (0.41) ALDH1A1HIF1AMEN1KMT2AMAPT
SCHEMBL19013546 0.86 ALDH1A1 (0.44) ALDH1A1HIF1AHPGDMEN1KMT2A
SCHEMBL29631881 0.86 ALDH1A1 (0.44) ALDH1A1HIF1AHPGDMEN1KMT2A
SCHEMBL18990424 0.85 MTHFD2 (0.37) ALDH1A1HIF1AHPGDMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12187728-B2 Caffeine inhibitors of MTHFD2 and uses thereof RAZE THERAPEUTICS, INC. (US) 2025-01-07 — — US disclosed
US-20230067237-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF RAZE THERAPEUTICS, INC. 2023-03-02 — — US disclosed
US-11370792-B2 Caffeine inhibitors of MTHFD2 and uses thereof RAZE THERAPEUTICS, INC. (US) 2022-06-28 — — US disclosed
US-20180370972-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF RAZE THERAPEUTICS, INC. 2018-12-27 — — US disclosed
EP-3389664-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF Raze Therapeutics Inc. (US) 2018-10-24 — — EP disclosed
WO-2017106352-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-06-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12187728-B2 Caffeine inhibitors of MTHFD2 and uses thereof MTHFD2, MTHFD1, NUDT15 ALDH1A1 260/4885HIF1A 2295/4885HPGD 188/4885
US-11370792-B2 Caffeine inhibitors of MTHFD2 and uses thereof MTHFD2, MTHFD1, NUDT15 ALDH1A1 260/4885HIF1A 2295/4885HPGD 188/4885
US-20230067237-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF MTHFD2, MTHFD1, NUDT15 ALDH1A1 260/4885HIF1A 2295/4885HPGD 188/4885
US-20180370972-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF MTHFD2, MTHFD1, NUDT15 ALDH1A1 260/4885HIF1A 2295/4885HPGD 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback